Association between HSP90 and Her2 in gastric and gastroesophageal carcinomas.
about
Epstein-barr virus in gastro-esophageal adenocarcinomas - single center experiences in the context of current literature.Immune microenvironment as a factor of breast cancer progression.Correlation between apparent diffusion coefficients and HER2 status in gastric cancers: pilot study.Efficient isolation and proteomic analysis of cell plasma membrane proteins in gastric cancer reveal a novel differentiation and progression related cell surface marker, R-cadherin.Image analysis of immunohistochemistry is superior to visual scoring as shown for patient outcome of esophageal adenocarcinoma.Native glycan fragments detected by MALDI-FT-ICR mass spectrometry imaging impact gastric cancer biology and patient outcome.Heat Shock Protein 90 (HSP90) and Her2 in Adenocarcinomas of the Esophagus.Prognostic significance of HER2 expression based on trastuzumab for gastric cancer (ToGA) criteria in gastric cancer: an updated meta-analysis.Methods and significance of the combined detection of HER2 gene amplification and chemosensitivity in gastric cancer.Therapeutic potency of heat-shock protein-90 pharmacological inhibitors in the treatment of gastrointestinal cancer, current status and perspectives.The role of heat shock proteins and co-chaperones in heart failure.Expression analysis of heat shock protein 90 (HSP90) and Her2 in colon carcinoma.Analysis of HSP90 Expression Is Valuable in the Differential Diagnosis of Ocular Surface Squamous Lesions.Prognosis significance of HER2 status and TACC1 expression in patients with gastric carcinoma.HDAC6 inhibitor TST strengthens the antiproliferative effects of PI3K/mTOR inhibitor BEZ235 in breast cancer cells via suppressing RTK activation
P2860
Q35218805-584028F7-37A0-42AD-A9ED-9E0275F77D58Q35780464-BB98DC9B-1FB9-4E90-B5DD-24A1CCDAD3E4Q35815603-795BDDE0-CF69-4C42-9300-98D81F478EBFQ37366255-6B5E479F-6756-4196-BB0F-1AD12CE467BAQ40217601-3A2807A2-7026-4101-B6BB-A184EEE663AAQ42366594-C06BEDC7-109A-46D7-8089-04F3092DD64AQ42936269-038C74F5-A3C1-46A4-A710-1E2DA6C6F62EQ43479667-8752131A-B7F2-4A0A-BC42-04453F302AEFQ47361762-F6E1ABC4-4733-4FD1-963E-6B46E6832948Q47694405-68BC2034-C780-4E26-9380-900AEAA98EF9Q51424623-22CCEF3D-A375-4C85-8B6B-6715CE6E544AQ53091400-AB43D525-EA59-465C-8532-A37CD94B6765Q54117138-87C29A2C-A706-48BB-BFCD-AAFDB4D0347BQ54316753-2B048425-64A8-4EF5-A3B0-ED9DAA3C9FC6Q58751858-48220E5C-15F2-438F-A6C1-D484741E6B65
P2860
Association between HSP90 and Her2 in gastric and gastroesophageal carcinomas.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Association between HSP90 and Her2 in gastric and gastroesophageal carcinomas.
@ast
Association between HSP90 and Her2 in gastric and gastroesophageal carcinomas.
@en
Association between HSP90 and Her2 in gastric and gastroesophageal carcinomas.
@nl
type
label
Association between HSP90 and Her2 in gastric and gastroesophageal carcinomas.
@ast
Association between HSP90 and Her2 in gastric and gastroesophageal carcinomas.
@en
Association between HSP90 and Her2 in gastric and gastroesophageal carcinomas.
@nl
prefLabel
Association between HSP90 and Her2 in gastric and gastroesophageal carcinomas.
@ast
Association between HSP90 and Her2 in gastric and gastroesophageal carcinomas.
@en
Association between HSP90 and Her2 in gastric and gastroesophageal carcinomas.
@nl
P2093
P2860
P50
P1433
P1476
Association between HSP90 and Her2 in gastric and gastroesophageal carcinomas.
@en
P2093
Alexander Novotny
Annette Feuchtinger
Axel Walch
Karen Becker
Karina Bauer
P2860
P304
P356
10.1371/JOURNAL.PONE.0069098
P407
P577
2013-07-11T00:00:00Z